Gen-Probe, Inc.

Bank of America, N.a., as Collateral Agent

Siobhan Miick

Paul M Darby

Jo Ann Jackson

Ankur Shah

Amber Hillius

Matthias Jost

Patrick Lynn Peterson

JoAnn Jackson

Matthew Brentnall

Hee Cheol Kim

Sheila MJ Aubin

Sheila M J Aubin

Joann Jackson

Compositions and Methods for Detecting or Quantifying Hepatitis C Virus

Oligomer nucleotides, compositions, methods, kits, and uses are provided for detecting or quantifying a Human Cytomegalovirus virus 1 (CMV (human herpesvirus 5, HHV5) nucleic acid, e.g., using nucleic acid amplification and hybridization assays. Multiphase amplification of a CMV target sequence is also described. The oligomer nucleotides, compositions, methods, kits, and uses can be used to amplify and/or detect the UL56 gene of CMV.

Compositions and methods for amplifying, detecting or quantifying human cytomegalovirus

Provided herein are compositions, kits, and methods for detecting methicillin-resistant(MRSA) nucleic acids. In some embodiments, the compositions, kits, and methods can be used to detect one or more of type i, ii, iii, iv, v, vi, vii, viii, ix, xii, xiii, xiv, xv, or xxi SCCmec right extremity junction (MREJ) MRSA nucleic acids and one or more of mecA, mecC, and/or an additional-specific gene.

Compositions and methods for detecting

This disclosure provides oligomers, compositions, and kits for detecting and quantifying Hepatitis C virus (HCV), including different genotypes and variants thereof, and related methods and uses. In some embodiments, oligomers target the 5' untranslated region of HCV and are configured to provide substantially equivalent quantification of different genotypes and variants of HCV.

Compositions and methods for detecting or quantifying hepatitis C virus

Growing community of inventors

San Diego, CA, United States of America

Siobhan Miick